Case number 1:23-cv-00684
AbbVie Inc. v. Sun Pharmaceutical Industries Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 21, 2024 | 11 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,542,239 B2. (Attachments: # 1 Stipulation of Dismissal)(ceg) (Entered: 06/21/2024) (0) |
| Aug 16, 2023 | 10 | SO ORDERED Granting (D.I. 12 in 23-cv-374-RGA; D.I. 13 in 23-cv-607-RGA; D.I. 6 in 23-cv-750-RGA; D.I. 12 in 23-cv-448-RGA; D.I. 9 in 23-cv-684-RGA; D.I. 113 in 22-cv-1423-RGA-JLH; D.I. 13 in 23-cv-00470-RGA) Stipulation and Proposed Order Concerning Amended Complaint and Consolidation (see Order for further details). Signed by Judge Richard G. Andrews on 8/16/2023. Associated Cases: 1:22-cv-01423-RGA-JLH et al.(nms) (Entered: 08/16/2023) (7) |
| Aug 10, 2023 | 9 | STIPULATION and Proposed Order Concerning Amended Complaint and Consolidation, AbbVie Inc., AbbVie Ltd., Neurocrine Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibits A-G, # 3 Supplemental ANDA form, # 4 Supplemental ANDA form, # 5 Supplemental ANDA form, # 6 Amended Patent Report, # 7 Exhibit 2)(Tigan, Jeremy) Modified on 8/10/2023 (nms). (Entered: 08/10/2023) (0) |
| Jul 24, 2023 | 8 | MOTION for Pro Hac Vice Appearance of Attorney Jennell C. Bilek, Samuel T. Lockner, Mitchell R. Williams, and Caroline L. Marsili - filed by Sun Pharmaceutical Industries Limited. (Wilson, Samantha) (Entered: 07/24/2023) (7) |
| Jul 14, 2023 | 6 | ANSWER to 1 Complaint and Separate Defenses, by Sun Pharmaceutical Industries Limited.(Gaza, Anne) Modified on 7/14/2023 (nms). (Entered: 07/14/2023) (26) |
| Jul 14, 2023 | 7 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Sun Pharmaceutical Industries Limited. (Wilson, Samantha) (Entered: 07/14/2023) (2) |
| Jun 28, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 06/28/2023) (0) |
| Jun 23, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Sun Pharmaceutical Industries Limited (Filing fee $ 402, receipt number ADEDC-4164902.) - filed by AbbVie Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (mkr) (Entered: 06/23/2023) (Main Document) (14) |
| Jun 23, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 06/23/2023) (3) |
| Jun 23, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 11, 2023. Date of Expiration of Patent: July 23, 2039. (mkr) (Entered: 06/23/2023) (1) |
| Jun 23, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,542,239 B2. (mkr) (Entered: 06/23/2023) (1) |
| Jun 23, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc. (mkr) (Entered: 06/23/2023) (1) |
| Jun 23, 2023 | N/A | No Summons Issued. (mkr) (Entered: 06/23/2023) (0) |
| Jun 23, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Sun Pharmaceutical Industries Limited (Filing fee $ 402, receipt number ADEDC-4164902.) - filed by AbbVie Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (mkr) (Entered: 06/23/2023) (Exhibit A) (30) |
| Jun 23, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Sun Pharmaceutical Industries Limited (Filing fee $ 402, receipt number ADEDC-4164902.) - filed by AbbVie Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (mkr) (Entered: 06/23/2023) (Civil Cover Sheet) (2) |
| Jun 23, 2023 | 1 | Complaint* (1) |
